Cadrenal Therapeutics CVKD
NASDAQ CVKD
$0.98 -0.10 (-8.95%)
As of: Oct 1, 2026 · 3:37 PM EDT

Cadrenal Therapeutics (CVKD) Accounts Payables (2022 - 2026)

Updated

Cadrenal Therapeutics' Accounts Payables was $871,913 in Q2 2026, down 2.6% from $895,609 a year earlier but up 5.7% from the prior quarter.

Analysis

Cadrenal Therapeutics (CVKD) Accounts Payables (2022 - 2026) Analysis & Trends

At the end of FY2025, Accounts Payables at Cadrenal Therapeutics came in at $650,663, down 56.7% from FY2024.

  • Accounts Payables shows a three-year compound annual growth rate of 17.1% (FY2022 to FY2025).
  • In earlier years, Accounts Payables was $1.5 million in FY2024 (+798.0%), $167,319 in FY2023 (-58.7%) and $404,897 in FY2022.
  • Quarterly Accounts Payables has moved between $78,139 (Q2 2023) and $1.5 million (Q4 2024) over five years.
  • Compared with a year earlier, Accounts Payables has declined for three straight quarters, with growth averaging 151.8% over the last eight quarters.
  • The best year-over-year quarter for Accounts Payables over five years was Q2 2024 (growth of 872.0%); the worst was Q4 2023 (a decline of 58.7%).
  • Per Business Quant data, CVKD's Accounts Payables in the three quarters before Q2 2026 was $824,809 (Q1 2026), $650,663 (Q4 2025) and $614,127 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 9.22 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 33.30 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 3.83 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 4.26 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -22.89 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 2.87 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 674.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.58 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 429.50 Mn
10 Cadrenal Therapeutics 3.35 Mn -9.27 Mn - 871,913.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 871,913.00
Mar 31, 2026 824,809.00
Dec 31, 2025 650,663.00
Sep 30, 2025 614,127.00
Jun 30, 2025 895,609.00
Mar 31, 2025 1.28 Mn
Dec 31, 2024 1.50 Mn
Sep 30, 2024 496,823.00
Jun 30, 2024 759,518.00
Mar 31, 2024 400,373.00
Dec 31, 2023 167,319.00
Sep 30, 2023 141,658.00
Jun 30, 2023 78,139.00
Mar 31, 2023 119,567.00
Dec 31, 2022 404,897.00
API Access

Cadrenal Therapeutics Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=CVKD&period=max&api_key=YOUR_API_KEY